Rite Aid Corporation operates retail drugstores in the United States. It is one of the countrys largest retail drugstore chains with 3,333 stores in operation as of March 3, 20X3. The companys drugstores primary business is pharmacy services. The company also sells a full selection of health and beauty aids and personal care products, seasonal merchandise, and a large private brand product line. The following condensed information was extracted from Rite Aids Form 10-K for the fiscal year that ended March 3, 20X3 (all dollars in thousands). Consolidated Statements of Cash FlowsOperating Activities Section Year Ended 3/3/20X3 3/4/20X2 2/26/20X1 Net Income $ 26,826 $ 1,273,006 $ 302,478 Total noncash charges (credits) 379,715 (810,731 ) 129,729 Changes in operating assets and liabilities: Net proceeds from accounts receivable securitization 20,000 180,000 150,000 Accounts receivable (39,543 ) (51,494 ) 36,549 Net changes in other operating assets and liabilities (77,853 ) (173,616 ) (100,310 ) Net cash provided by operating activities $ 309,145 $ 417,165 $ 518,446 Consolidated Statements of Operations Year Ended 3/3/20X3 3/4/20X2 2/26/20X1 Revenues $ 17,507,719 $ 17,270,968 $ 16,816,439 Costs and expenses Cost of goods sold 12,791,597 12,571,860 12,202,894 Selling, general, and administrative expenses 4,370,481 4,307,421 4,127,536 Store closing and impairment charges 49,317 68,692 35,655 Interest expense 275,219 277,017 294,871 Loss on debt modifications and retirements, net 18,662 9,186 19,229 (Gain) loss on sale of assets, net (11,139 ) (6,462 ) 2,247 17,494,137 17,227,714 16,682,432 Income before income taxes 13,582 43,254 134,007 Income tax benefit (13,244 ) (1,229,752 ) (168,471 ) Net income $ 26,826 $ 1,273,006 $ 302,478 Selected Data Pertaining to Accounts Receivable Year Ended 3/3/20X3 3/4/20X2 2/26/20X1 Year-end Accounts receivable, net $ 374,493 $ 354,949 $ 483,455 Allowance for uncollectible accounts at year-end 30,246 32,336 31,216 Additions to uncollectible accounts charged to costs and expenses 26,603 34,702 47,291 Accounts Receivable The Company maintains an allowance for doubtful accounts receivable based upon the expected collectibility of accounts receivable. The allowance for uncollectible accounts at March 3, 20X3, and March 4, 20X2, was $30,246 and $32,336, respectively. The Companys accounts receivable are due primarily from third-party payors (e.g., pharmacy benefit management companies, insurance companies, or governmental agencies) and are recorded net of any allowances provided for under the respective plans. Since payments due from third-party payors are sensitive to payment criteria changes and legislative actions, the allowance is reviewed continually, and adjusted for accounts deemed uncollectible by management. The Company maintains securitization agreements with several multiseller asset-backed commercial paper vehicles (CPVs). Under the terms of the securitization agreements, the Company sells substantially all of its eligible third-party pharmaceutical receivables to a bankruptcy remote Special Purpose Entity (SPE) and retains servicing responsibility. The assets of the SPE are not available to satisfy the creditors of any other person, including any of the Companys affiliates. These agreements provide for the Company to sell, and for the SPE to purchase these receivables. The SPE then transfers an interest in these receivables to various CPVs. Transferred outstanding receivables cannot exceed $400,000. The amount of transferred receivables outstanding at any one time is dependent upon a formula that takes into account such factors as default history, obligor concentrations, and potential dilution (Securitization Formula). Adjustments to this amount can occur on a weekly basis. At March 3, 20X3, and March 4, 20X2, the total of outstanding receivables that have been transferred to the CPVs were $350,000 and $330,000, respectively. The Company has determined that the transactions meet the criteria for sales treatment in accordance with (pre-Codification) SFAS No. 140 Accounting for Transfers and Servicing of Financial Assets and Extinguishment of Liabilities.

Required: Calculate cash collected from customers during fiscal 20X3. 17441572

Had Rite Aid not securitized receivables during 20X3, 20X2, and 20X1, what would its operating cash flows have been in each of these years?

X1=368446; X2=237165; X3=289145

I NEED HELP WITH THIS PART AND PLEASE EXPLAIN: Calculate pre-tax operating income for 20X3, 20X2, and 20X1.